Loading
Every trade that managers of בונוס ביוגרופ disclose to TASE (ISA) is tracked on this page. Between 18 October 2025 and 18 October 2026, 6 insiders published 18 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Across the 530 companies tracked on its exchange, the median is 14 filings; at 18 filings, this issuer sits above that mark.
There has been no open-market purchase by an insider of בונוס ביוגרופ for at least a year.
These figures are compiled from regulatory filings published by TASE (ISA). They describe what insiders did and are not a recommendation.
· cache
18 of 18 declarations
Bounos Biogroup is a publicly traded company on the Tel Aviv Stock Exchange, specializing in the biotechnology sector. It focuses on developing innovative solutions for the healthcare industry.